Purified recombinant hARD1 does not catalyse acetylation of Lys532 of HIF-1alpha fragments in vitro
about
Composition and biological significance of the human Nα-terminal acetyltransferasesCharacterization of the native and fibrillar conformation of the human Nalpha-acetyltransferase ARD1Phosphorylation of ARD1 by IKKbeta contributes to its destabilization and degradationExpression, crystallization and preliminary X-ray crystallographic analyses of two N-terminal acetyltransferase-related proteins from Thermoplasma acidophilumARD1 stabilization of TSC2 suppresses tumorigenesis through the mTOR signaling pathwayEffects of histone deacetylase inhibitors on HIF-1The histone deacetylase Sirt6 regulates glucose homeostasis via Hif1alphaThe biological functions of Naa10 - From amino-terminal acetylation to human diseaseProtein N-terminal acetyltransferases in cancer.Histone deacetylase inhibitors: the epigenetic therapeutics that repress hypoxia-inducible factors.Mdm20 stimulates polyQ aggregation via inhibiting autophagy through Akt-Ser473 phosphorylation.The N-terminal Acetyltransferase Naa10/ARD1 Does Not Acetylate Lysine Residues.Transcriptional regulation by hypoxia inducible factors.HDAC6 regulates sensitivity to cell death in response to stress and post-stress recoveryVorinostat suppresses hypoxia signaling by modulating nuclear translocation of hypoxia inducible factor 1 alpha.Hepatitis B virus X protein induces the expression of MTA1 and HDAC1, which enhances hypoxia signaling in hepatocellular carcinoma cells.Epigenetic regulators: multifunctional proteins modulating hypoxia-inducible factor-α protein stability and activity.FIH permits NAA10 to catalyze the oxygen-dependent lysyl-acetylation of HIF-1α
P2860
Q21202069-C4042F8B-AED3-44A6-8848-A76190C165D1Q24647644-B8122409-486C-414B-9262-37AB54886045Q28256858-2B5E1DCB-3D41-4DA3-A7DC-6FC26115FB8AQ28271412-66CDDB20-F7E0-46C6-82A9-6036459D8AF4Q28272830-940C9512-2A93-4E22-B6B7-FC4C03F45AECQ28273896-29A20027-A3CB-44E9-9A54-3AF86490539BQ28588941-2B070607-7A51-4D03-B75B-F3D0C29EAE36Q28638824-33E88231-8C7F-436A-9DEA-A3CB24B8A03CQ34258775-39656921-480B-410E-BD81-625CE8B33EBBQ34382527-940C929A-E66B-4C55-AB9B-E16F1EB253E2Q35072813-2132D56B-5A39-4C79-B086-254E2EA2CF4AQ36650378-56DC26FF-0481-47E8-86C2-22CB1DFEB905Q38149945-07D99027-09D7-42C4-A486-A8951E7B4D40Q39002935-F9FF0DAD-4199-434A-AF48-A1E5EA315AB7Q41347745-31BB91AE-A32F-46F4-B706-D65B103E05A8Q45397229-7CC0796D-9A24-4AC7-9644-4D782DDF6488Q47651765-C058C18C-5B70-4F2D-9A3F-7F31BA145319Q58758683-E3525EB5-492E-484D-9899-9C8ADCEAB447
P2860
Purified recombinant hARD1 does not catalyse acetylation of Lys532 of HIF-1alpha fragments in vitro
description
2006 nî lūn-bûn
@nan
2006 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Purified recombinant hARD1 doe ...... HIF-1alpha fragments in vitro
@ast
Purified recombinant hARD1 doe ...... HIF-1alpha fragments in vitro
@en
Purified recombinant hARD1 doe ...... HIF-1alpha fragments in vitro
@nl
type
label
Purified recombinant hARD1 doe ...... HIF-1alpha fragments in vitro
@ast
Purified recombinant hARD1 doe ...... HIF-1alpha fragments in vitro
@en
Purified recombinant hARD1 doe ...... HIF-1alpha fragments in vitro
@nl
prefLabel
Purified recombinant hARD1 doe ...... HIF-1alpha fragments in vitro
@ast
Purified recombinant hARD1 doe ...... HIF-1alpha fragments in vitro
@en
Purified recombinant hARD1 doe ...... HIF-1alpha fragments in vitro
@nl
P2860
P1433
P1476
Purified recombinant hARD1 doe ...... HIF-1alpha fragments in vitro
@en
P2093
Kirsty S Hewitson
Thomas A Murray-Rust
P2860
P304
P356
10.1016/J.FEBSLET.2006.02.012
P407
P577
2006-04-03T00:00:00Z